Notice of Final Rule re Charging for Investigational Drugs Under an Investigational New Drug Application (US Food and Drug Administration Regulation)
Overview
Notice of Final Rule re Charging for Investigational Drugs Under an Investigational New Drug Application (US Food and Drug Administration Regulation) (FDA) (2018 Edition) The Law Library presents the complete text of the Notice of Final Rule re Charging for Investigational Drugs Under an Investigational New Drug Application (US Food and Drug Administration Regulation) (FDA) (2018 Edition). Updated as of May 29, 2018 The Food and Drug Administration (FDA) is amending its investigational new drug application (IND) regulation concerning charging patients for investigational new drugs. This final rule revises the charging regulation to clarify the circumstances in which charging for an investigational drug in a clinical trial is appropriate, to set forth criteria for charging for an investigational drug for the different types of expanded access for treatment use described in the agency's final rule on expanded access for treatment use of investigational drugs published elsewhere in this issue of the Federal Register, and to clarify what costs can be recovered for an investigational drug. This final rule will permit charging for a broader range of uses than was explicitly permitted previously. This book contains: - The complete text of the Notice of Final Rule re Charging for Investigational Drugs Under an Investigational New Drug Application (US Food and Drug Administration Regulation) (FDA) (2018 Edition) - A table of contents with the page number of each section
This item is Non-Returnable
Customers Also Bought
Details
- ISBN-13: 9781727529838
- ISBN-10: 1727529839
- Publisher: Createspace Independent Publishing Platform
- Publish Date: September 2018
- Dimensions: 10 x 7 x 0.13 inches
- Shipping Weight: 0.27 pounds
- Page Count: 62
Related Categories
